FDA Approves Gilead's Once-Daily Combination Pill for Suppressed HIV Patients
The US Food and Drug Administration has approved Gilead Sciences' (GILD) once-daily oral combination pill for the treatment of adults whose HIV infection has already been reduced to undetectable levels, the California-based drugmaker said.
